Herpes simplex virus type 2 infection in young adult women: Risk factors for infection and frequency of viral shedding

Sexually Transmitted Diseases

Volumn 37, Issue 4, 2010, Pages 248-252

  Fife, Kenneth H ^a   Williams, James A ^a   Thomas, Allyson L ^a   Ofner, Susan ^a   Katz, Barry P ^a   Fortenberry, J Dennis ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ADULT; ADULT DISEASE; ARTICLE; BLOOD SAMPLING; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; RISK FACTOR; SEXUAL BEHAVIOR; SYMPTOM; VIRUS SHEDDING;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; LOGISTIC MODELS; MEDICAL RECORDS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; UNITED STATES; VAGINA; VIRUS SHEDDING; YOUNG ADULT;

EID: 78650774417     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181d4f866     Document Type: Article

References (33)

1. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A metaanalysis. J Infect Dis 2002; 185:45-52.
2. Serwadda D, Gray RH, Sewankambo NK, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: A nested case-control study in Rakai, Uganda. J Infect Dis 2003; 188:1492-1497.
3. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics. J Acquir Immun Defic Syndr 2004; 35:435-445.
4. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
5. Brown JM, Wald A, Hubbard A, et al. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS 2007; 21:1515-1523.
6. Abu-Raddad LJ, Magaret AS, Celum C, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One 2008; 3:e2230.
7. van de Wijgert JH, Morrison CS, Brown J, et al. Disentangling ontributions of reproductive tract infections to HIV acquisition in African women. Sex Transm Dis 2009; 36:357-364.
8. Schacker T, Zeh J, Hu HL, et al. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186:1718-1725.
9. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-799.
10. LeGoff J, Weiss HA, Gresenguet G, et al. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes. AIDS 2007; 21:1569-1578.
11. Baeten JM, Strick LB, Lucchetti A, et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: A randomized, placebo-controlled, cross-over trial. J Infect Dis 2008; 198:1804-1808.
12. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Org 2008; 86:805-812.
13. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-973.
14. Fife KH, Fortenberry JD, Ofner S, et al. Incidence and prevalence of herpes simplex virus infections in adolescent women. Sex Transm Dis 2006; 33:441-444.
15. Batteiger BE, Tu W, Ofner S, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis. 2010; 201:42-51.
16. Tu W, Batteiger BE, Wiehe S, et al. Time from first intercourse to first sexually transmitted infection among adolescent women. Arch Pediatr Adolesc Med. 2009;163:1106-1111.
17. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2007. Vol 19. Atlanta, GA: US Department of Health and Human Services. Centers for Disease Control and Prevention, 2009.
18. Freeman EE, Orroth KK, White RG, et al. Proportion of new HIV infections attributable to herpes simplex 2 increases over time: Simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Inf 2007; 83(suppl 1):i17-i24.
19. Forna FM, Fitzpatrick L, Adimora AA, et al. A case-control study of factors associated with HIV infection among black women. J Natl Med Assoc 2006; 98:1798-1804.
20. Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet 2008; 372:337-340.
21. Brock BV, Selke S, Benedetti J, et al. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 1990; 263:418-420.
22. Wald A, Zeh J, Barnum G, et al. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996; 124:8-15.
23. Wald A, Corey L, Cone R, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women - Effect of acyclovir treatment. J Clin Invest 1997; 99:1092-1097.
24. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844-850.
25. Mark KE, Wald A, Magaret AS, et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 2008; 198:1141-1149.
26. Leone P, Warren T, Hamed K, et al. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons. Sex Transm Dis 2007; 34:900-907.
27. Sperling RS, Fife KH, Warren TJ, et al. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sex Transm Dis 2008; 35:286-290.
28. Crespi CM, Cumberland WG, Wald A, et al. Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modeling. Sex Transm Inf 2007; 83:365-368.
29. Langenberg A, Benedetti J, Jenkins J, et al. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med 1989; 110:882-887.
30. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomized, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-2119.
31. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571.
32. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652-1661.
33. Xu F, Schillinger JA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988 -1994. J Infect Dis 2002; 185:1019-1024.